BKHA: SEC Form CERT filed by Black Hawk Acquisition Corporation
Black Hawk Acquisition Corporation (BKHA) filed an SEC Form CERT. The company operates in the biotechnology sector, focusing on biological products. It has been listed since 2024.
Black Hawk Acquisition Corp
Black Hawk Acquisition Corp. is a blank-check company formed to merge with, acquire or combine with one or more businesses. Since its initial public offering, its sole business activity is identifying and evaluating acquisition candidates. It has no revenue and has relied on securities sales and loans to fund operations. Black Hawk earns no operating income from products or services; its funds are intended mainly for completing a business combination and working capital. It seeks private companies that could benefit from access to U.S. public capital markets, with no geographic restriction on potential targets. Black Hawk entered into a Business Combination Agreement with Vesicor Therapeutics, Inc. and BH Merger Sub, Inc. on April 26, 2025, and is focused on completing that proposed transaction. Its securities include units made up of ordinary shares and rights. Black Hawk is incorporated in the Cayman Islands and is based in Danville, California.
No SEC Form 4 filings for $BKHA in the last 30 days.
See all $BKHA insider activity →Black Hawk Acquisition Corporation (BKHA) filed an SEC Form CERT. The company operates in the biotechnology sector, focusing on biological products. It has been listed since 2024.
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. ITEM 8.01. Other Events. On October 22, 2026, an aggregate of $150,000 (the “Extension Payment”) was deposited into the trust account of Black Hawk Acquisition Corporation (the “Company”) for its public shareholders, which enables the Company to further extend the period of time
Black Hawk Acquisition (BKHA) reported $25.15M in share redemptions ahead of its merger with Vesicor, leaving $420K in trust and 2.06M shares outstanding. The redemptions reduce available deal cash.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning BKHA (Black Hawk Acquisition Corp). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent BKHA coverage spans corporate actions, financial news and earnings.
The filing introduces a new securities registration, which may dilute existing shares and create modest selling pressure.
The modest extension payment is unlikely to move the stock significantly but confirms the SPAC remains on track to seek a deal.
Share redemptions drain cash, likely pressuring the SPAC's share price lower.
Black Hawk Acquisition Corp. (BKHAU, BKHA, BKHAR) announced that 2.09 million shareholders redeemed their shares, generating $25M in payments. The redemption is related to its proposed business combination with Vesicor Therapeutics Inc. (VESI), a preclinical-stage biotech company. The combined entity is expected to list on NASDAQ under the symbol VESI.
Approval of the business combination and domestication removes regulatory hurdles and moves the SPAC toward closing, likely supporting the stock.
AlphAI scores every news story that mentions BKHA with an AI model for sentiment and relevance, and aggregates insider trades from Black Hawk Acquisition Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Black Hawk Acquisition Corporation (BKHA) filed an SEC Form CERT. The company operates in the biotechnology sector, focusing on biological products. It has been listed since 2024.
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. ITEM 8.01. Other Events. On October 22, 2026, an aggregate of $150,000 (the “Extension Payment”) was deposited into the trust account of Black Hawk Acquisition Corporation (the “Company”) for its public shareholders, which enables the Company to further extend the period of time
Black Hawk Acquisition (BKHA) reported $25.15M in share redemptions ahead of its merger with Vesicor, leaving $420K in trust and 2.06M shares outstanding. The redemptions reduce available deal cash.
Black Hawk Acquisition Corp. (BKHAU, BKHA, BKHAR) announced that 2.09 million shareholders redeemed their shares, generating $25M in payments. The redemption is related to its proposed business combination with Vesicor Therapeutics Inc. (VESI), a preclinical-stage biotech company. The combined entity is expected to list on NASDAQ under the symbol VESI.
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of a Matter to a Vote of Security Holders. On October 13, 2026, Black Hawk Acquisition Corporation (the “Company”) held an extraordinary general meeting of Shareholders (the “Extraordinary General Meeting”). The record date for shareholders entitled to notice
Wolverine Asset Management, Wolverine Holdings, and two managers reported a 5.09% stake in Black Hawk Acquisition Corp., owning 211,220 shares each. Wolverine Holdings and the managers also claim beneficial ownership of 221,220 shares, with shared voting and dispositive power. The percentages are based on 4,153,577 outstanding shares as of July 15, 2026, according to the filing.
Black Hawk Acquisition Corp (BKHA) reported Q3 2026 net income of $1.07M, up 596.6% YoY, with EPS of $0.26, up 766.7%. Revenue grew mid-single digits YoY, driven by core products and e-commerce. Management expects continued margin improvement and modest top-line growth.
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company (“BKHA” or the “Company”), and Vesicor Therapeutics, Inc., a California corporation (“Vesicor”), entered into a series of financing a
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 22, 2026 Black Hawk Acquisition Corporation (Exact Name of Registrant as Specified in i
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On August 21, 2026, Black Hawk Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued a convertible promissory note (the “Note”) in the principal amount of up to $300,000 to Black Hawk Management LLC (the